TMC1: A Potential Drug Target and Biomarker (G117531)

Target Name: TMC1

NCBI ID: G117531

TMC1

TMC1: A Potential Drug Target and Biomarker

TMC1, also known as thrombin-concentin (Tc), is a protein that is expressed in various tissues and cells, including platelets, endothelial cells, and cancer cells. It plays a critical role in the process of blood clotting and has been linked to the development and progression of various diseases, including cancer. Therefore, targeting TMC1 has been identified as a promising strategy for the development of new treatments for these diseases.

Recent studies have shown that TMC1 is involved in several cellular processes that are crucial for cancer progression, including angiogenesis, invasion, and metastasis. Its expression has also been observed in various types of cancer, including breast, lung, and colorectal cancer. Therefore, targeting TMC1 may be an effective way to inhibit the growth and progression of cancer cells.

In addition to its role in cancer, TMC1 has also been linked to the development of cardiovascular diseases. Its expression has been observed in various cardiovascular tissues, including the heart, blood vessels, and platelets. Therefore, targeting TMC1 may be a promising strategy for the development of new treatments for cardiovascular diseases.

TMC1 has also been shown to play a role in inflammation. Its expression has been observed in various inflammatory tissues, including the liver, spleen, and skin. Therefore, targeting TMC1 may be an effective way to inhibit the production of pro-inflammatory molecules that contribute to inflammation.

In conclusion, TMC1 is a protein that has been identified as a potential drug target and biomarker for several diseases, including cancer, cardiovascular diseases, and inflammation. Further research is needed to fully understand its role and potential as a drug target and biomarker.

Protein Name: Transmembrane Channel Like 1

Functions: Probable ion channel required for the normal function of cochlear hair cells

The "TMC1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMC1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets